Liyun Xu
Overview
Explore the profile of Liyun Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu L, Shen T, Li Y, Wu X
Clin Rev Allergy Immunol
. 2025 Mar;
68(1):29.
PMID: 40085180
N6-methyladenosine (mA), a prevalent and essential RNA modification, serves a key function in driving autoimmune disease pathogenesis. By modulating immune cell development, activation, migration, and polarization, as well as inflammatory...
2.
Han D, He C, Gu S, Zhang D, Xu L
Pak J Med Sci
. 2024 Nov;
40(10):2416-2421.
PMID: 39554684
Objective: To explore the clinical value of computed tomography (CT) liver-to-spleen (L/S) attenuation ratio in patients with non-alcoholic fatty liver disease (NAFLD) accompanied by atherosclerotic plaque (AP). Methods: This was...
3.
Chen C, Zhao F, Peng J, Zhao D, Xu L, Li H, et al.
Cell Rep Med
. 2024 Aug;
5(8):101686.
PMID: 39168104
Resistance to PD-1 blockade in onco-immunotherapy greatly limits its clinical application. T cell immunoglobulin and mucin domain containing-3 (Tim-3), a promising immune checkpoint target, is cleaved by ADAM10/17 to produce...
4.
You C, Xu L, Zhu L, Qiu S, Xu N, Wang Y, et al.
Seizure
. 2024 Jul;
121:38-44.
PMID: 39068850
Introduction: Increasing evidence reveals critical roles for CHD2 in children with developmental and epileptic encephalopathy. Objectives: The aim was to present clinical analysis results of five cases with CHD2 mutations...
5.
Jiang Z, Liu M, Zhou L, Chen W, Lou L, Xu L
J Vasc Access
. 2024 Apr;
:11297298241245742.
PMID: 38600613
Background: Autogenous arteriovenous fistula (AVF) is the preferred vascular access mode. However, the earliest possible time for AVF puncture and whether premature puncture affects the AVF patency rate remain unclear....
6.
Zhao Y, Chen K, Zhu J, Chen H, Xia Y, Xu M, et al.
Molecules
. 2024 Mar;
29(6).
PMID: 38542857
To produce functional protective textiles with minimal environmental footprints, we developed durable superhydrophobic antimicrobial textiles. These textiles are characterized by a micro-pleated structure on polyester fiber surfaces, achieved through a...
7.
Zhang X, Han Y, Yang L, Xu N, Zhu L, Qiu S, et al.
Seizure
. 2023 Dec;
114:111-120.
PMID: 38134649
Purpose: Seizure threshold 2 protein homolog gene (SZT2, MIM: 615463) related diseases are extremely rare autosomal recessive disorders with a wide spectrum of clinical phenotypes ranging from mild intellectual impairment...
8.
Xu L, Fan L, Zhu J
Int J Nanomedicine
. 2023 Oct;
18:5579-5590.
PMID: 37808456
Background: Small cell lung cancer (SCLC) is a common subtype of lung cancer, and there is currently no established method for the early identification of SCLC. We prepared a novel...
9.
Xu Y, Hsu J, Xu L, Chen W, Cai W, Wang K
J Nanobiotechnology
. 2023 Jul;
21(1):211.
PMID: 37415158
Lung cancer has been the leading cause of cancer-related deaths worldwide for decades. Despite the increasing understanding of the underlying disease mechanisms, the prognosis still remains poor for many patients....
10.
Zhang C, Xu L, Ma Y, Huang Y, Zhou L, Le H, et al.
J Thorac Dis
. 2023 Apr;
15(3):1433-1444.
PMID: 37065598
Background: T-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) is considered a key negative regulator in T-cell-mediated response. However, few studies have been reported on the relationship between TIM-3 expression...